The Rosen Law Firm Announces Investigation Against Tibet Pharmaceuticals, Inc.

The Rosen Law Firm, P.A. announces that it is investigating potential securities claims against Tibet Pharmaceuticals, Inc. (NASDAQ: TBET) (“Tibet Pharma”). On April 3, 2012 the NASDAQ stock market announced that it had halted trading in Tibet Pharma stock for “additional information requested.” The trading halt has rendered Tibet Pharma stock illiquid.

The Rosen Law Firm is investigating potential securities claims against Tibet Pharmaceuticals in connection with the trading halt. If you purchased Tibet Pharmaceuticals stock or have information that you believe may assist the firm’s investigation please visit the website at http://www.rosenlegal.com. You may also contact Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.